U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07224607) titled 'Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study' on Nov. 01.
Brief Summary: The purpose of this study is to see if a special light treatment, called photobiomodulation, can help people with memory problems such as Mild Cognitive Impairment or Mild Dementia due to Alzheimer's disease. The light is given to the forehead using an FDA-cleared medical device. This device is cleared to provide topical heating to elevate tissue temperature for temporary relief of muscle and joint pain, muscle spasm and stiffness associated with arthritis. It also increases blood circulation and relaxes muscle tissue. This device is being...